Aliceblue ANT
Aliceblue ANTInstall and trade smarter everywhere

Lupin stock jumps after securing SBTi validation for emission reduction targets

News by Aliceblue News Desk

16 Dec 2025

Lupin stock jumps after securing SBTi validation for emission reduction targets

Introduction

Leading global pharmaceutical company received SBTi validation for greenhouse gas emission reduction targets, covering Scope 1, 2, and 3, aiming significant reductions by FY2030 and FY2033 under Paris Agreement guidelines.

Alice Blue Image

Also Read: Adani Energy Solutions shares jump after acquiring KPS III HVDC Transmission

Share price movement of Lupin

On December 16, 2025, Lupin Limited opened at ₹2,087.25, down 0.14% from its previous close of ₹2,090.15. The stock reached a high of ₹2,100.50 (0.50%) and a low of ₹2,078.15 (-0.57%). By 2:35 PM, it traded at ₹2,083.20, a 0.33% decrease, with a market cap of ₹95,152.70 crore.

Lupin Achieves SBTi Validation for Emissions

Lupin Limited received official validation from the Science Based Targets initiative (SBTi) for its greenhouse gas emissions reduction targets. The validation covers Scope 1, Scope 2, and Scope 3 emissions.

The targets align with the Paris Agreement to limit global temperature rise to 1.5°C. Lupin aims to reduce Scope 1 and 2 emissions by 42% by FY2030, using FY2023 as the base year.

The company plans to cut Scope 3 emissions by 61.07% by FY2033. This covers goods, services, transportation, business travel, and product use, with FY2024 as the baseline for calculations.

Stock performance of Lupin for Period of 1 week, 6 months, and 1 year

Lupin Limited delivered a 1.99% return over the past week, it gained 8.32% in the past six months. The stock rose 1.42% over the past year.

Alice Blue Image

Also Read: GPT Infraprojects stock rises 5% after winning Rs. 1,739.49 crore L1 order

Shareholding pattern of Lupin

ParticularsSep 2025Jun 2025Mar 2025
Promoter46.90%46.90%46.90%
FII20.50%21.30%21.50%
DII26.60%25.60%25.40%
Public6.10%6.30%6.20%

About Lupin

Lupin Limited (NSE: LUPIN) is a global pharmaceutical company headquartered in Mumbai, operating in over 100 markets, with 15 manufacturing sites, 7 research centers, and a workforce of over 24,000 professionals.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Lupin Limited share price in focus today?

A: Lupin Limited share price is in focus after receiving SBTi validation for Scope 1, 2, and 3 greenhouse gas emissions targets. (16 Dec 2025)

Q: What does Lupin Limited specialize in?

A: Lupin Limited specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.

Q: What is the market capitalization of Lupin Limited?

A: The market capitalization of Lupin Limited is ₹95,152.70 crore as per the latest trading data on 16 Dec 2025.

author

News Author

Aliceblue News Desk

Take Your First Step Into The Market With₹0 Opening Charges

Open Free Demat Account
Alice Blue app on two phones